STO Equity Snapshot

DMYD-B Weekly Equity Report

Diamyd Medical AB (publ)

Interactive chart JSON snapshot
Latest Close 1.15 SEK 12 Jun 2026
1W Return 2.5% latest completed week
4W Return -1.9% short-term follow-through
12W Return -91.5% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
Company Brief

What the company does

Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes in adults (LADA); and Remygen, an immunomodulation therapy, that is in phase I/II clinical trial for the treatment of with type 1 diabetes, type 2 diabetes, and LADA. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in type 1 diabetes. Diamyd Medical AB (publ) was …

Snapshot

What the weekly tape is saying

DMYD-B closed the latest completed week at 1.15 SEK. The 4-week return is -1.9% and the 12-week return is -91.5%. Trend Signal is inactive, Market Dynamics is -1.03. Setup signature: Risk-first tape with a 10/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -86.7%
Volume 0.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 22 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 32 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 7 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
8.64 SEK
Vs Trend Line
-86.7%
Fair Value
10.86 SEK
Vs Fair Value
-89.4%
52W High
17.88 SEK
52W Low
0.90 SEK
Drawdown
-93.6%
Range Position
1.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 2.5%
4W -1.9%
12W -91.5%
26W -88.1%
52W -88.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
21
52W Active Breadth
40.4%
Sector Scope
SE Healthcare
Sector Rank
45 of 158
Sector Percentile
72.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.03
4W MD Change
9.0%
Relative Strength
-89.11
4W RS Change
0.4%
Expectation
Undecided
Probability
53.91%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
2.7M
13W Average
16.2M
52W Average
5.6M
Vs 13W
0.2x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
24.4%
52W Volatility
14.2%
Upside Weeks
28
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
5.2% / -8.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
STO
Country
SE
Sector
Healthcare
Industry
Biotechnology
Currency
SEK
Market Cap
152.9M

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 1.15 SEK 2.5% 8.64 SEK 10.86 SEK -1.03 -89.11 2.7M Off
5 Jun 2026 1.12 SEK 0.4% 8.93 SEK 10.90 SEK -1.08 -89.60 7.2M Off
29 May 2026 1.12 SEK 0.2% 9.24 SEK 10.95 SEK -1.11 -89.91 4.8M Off
22 May 2026 1.12 SEK -4.8% 9.54 SEK 10.99 SEK -1.12 -90.12 6.6M Off
15 May 2026 1.17 SEK -2.7% 9.86 SEK 11.04 SEK -1.13 -89.44 6.9M Off
8 May 2026 1.20 SEK 11.1% 10.17 SEK 11.13 SEK -1.12 -89.47 12.5M Off
1 May 2026 1.08 SEK 1.3% 10.49 SEK 11.21 SEK -1.12 -90.64 13.3M Off
24 Apr 2026 1.07 SEK -23.0% 10.84 SEK 11.33 SEK -1.04 -91.06 15.3M Off
17 Apr 2026 1.39 SEK -2.9% 11.17 SEK 11.45 SEK -0.63 -88.84 21.4M Off
10 Apr 2026 1.43 SEK 0.8% 11.48 SEK 11.56 SEK -0.25 -88.40 23.8M Off
3 Apr 2026 1.42 SEK -89.4% 11.81 SEK 11.67 SEK 0.13 -88.11 80.1M Off
27 Mar 2026 13.44 SEK -0.7% 12.17 SEK 11.76 SEK 0.51 14.76 12.6M On
20 Mar 2026 13.54 SEK -3.4% 12.10 SEK 11.77 SEK 0.62 16.37 3.4M On
13 Mar 2026 14.02 SEK -5.4% 12.03 SEK 11.77 SEK 0.79 15.19 2.0M On